Patent Assignment
Reel/Frame 068813/0398
Assignment of Assignor's Interest
Recorded: 2024-10-07
Pages: 7
Assignor
CHRISTENSEN, DALE J.
Executed: 2024-04-16
Assignee
LUNG THERAPEUTICS, LLC
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TEXAS, 78758
Covered Properties
(3)
Epithelial Sodium Channel (Enac) Inhibitor Conjugates and Methods for Use Thereof
Application:
18/577,028 →
Publication:
US 2024/0374585
Epithelial Sodium Channel (Enac) Inhibitor Conjugates and Methods for Use Thereof
Application:
63/219,488 →
Epithelial Sodium Channel (Enac) Inhibitor Conjugates and Methods for Use Thereof
Application:
63/243,629 →
PCT:
PCT/US2022/073561 ↗
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 13, 2021
From: CHRISTENSEN, DALE J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057171/0404 →
Assignment of Assignor's Interest
Oct 29, 2021
From: CHRISTENSEN, DALE J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 057957/0834 →
Assignment of Assignor's Interest
Apr 4, 2024
From: CHRISTENSEN, DALE J.
To: LUNG THERAPEUTICS, INC.
Reel/Frame 067011/0648 →
Merger and Change of Name
Apr 9, 2024
From: LUNG THERAPEUTICS, INC.; AT MERGER SUB II, LLC
To: LUNG THERAPEUTICS, LLC
Reel/Frame 067041/0773 →
Assignment of Assignor's Interest
Mar 3, 2025
From: LUNG THERAPEUTICS, LLC
To: REIN THERAPEUTICS, INC.
Reel/Frame 070384/0082 →